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It is now well established that, upon depletion of the stores, both molecules can accumulate and colocalize in specific areas (puncta) where the endoplasmic reticulum comes in close proximity to the plasma membrane. Some models propose a direct interaction between STIM1 and Orai1 as the most straightforward mechanism for signal transduction from the stores to the plasma membrane. To test some of the predictions of a conformational coupling model, we assessed how tight the relationships are between STIM1 and Orai1 expression, puncta formation, and SOCE activation. Here we present evidence that STIM1 accumulates in puncta equally well in the presence or absence of Orai1 expression, that STIM1 accumulation is not sufficient for Orai1 accumulation in the same areas, and that normal Ca 2ϩ releaseactivated Ca 2ϩ current (ICRAC) can be activated in STIM1-deficient cells. These data challenge the idea of direct conformational coupling between STIM1 and Orai1 as a viable mechanism of puncta formation and SOCE activation and uncover greater complexity in their relationship, which may require additional intermediate elements.
store-operated Ca 2ϩ entry STORE-OPERATED CA 2ϩ ENTRY (SOCE) is activated upon depletion of endoplasmic reticulum (ER) Ca 2ϩ stores (for review see Ref. 25) . Recently, two important components of SOCE were identified, stromal interaction molecule 1 (STIM1) as a Ca 2ϩ sensor in the ER, which is capable of triggering a cascade of reactions leading to SOCE activation, and Orai1 (also called CRACM1) as a plasma membrane (PM) channel that is activated by the store-operated pathway (for recent review see Ref. 13 ). STIM1 is a protein predominantly located in the ER membrane; it has one transmembrane domain and an EF hand motif in its NH 2 terminus, which allows STIM1 to bind Ca 2ϩ in the ER lumen and to function as a low-affinity Ca 2ϩ sensor in the stores. Upon Ca 2ϩ depletion, STIM1 can lose Ca 2ϩ from its EF hand, oligomerize, and accumulate into punctate structures in the ER membrane located in close proximity (10 -25 nm) to the PM (1, 14 -16, 20, 22, 23, 29, 36, 40) . Orai1 is a PM protein that is thought to be a pore-forming subunit of Ca 2ϩ release-activated Ca 2ϩ channel (CRAC) (9, 19, 20, 39, 41) . In resting cells, Orai1 is homogenously distributed in the PM, and, after store depletion, it was shown to accumulate in puncta and colocalize with STIM1. Molecular knockdown of either STIM1 or Orai1 has been shown to impair SOCE in a wide variety of cell types (see Ref. 13 for complete review), but their relationship is far from being understood.
Several groups have proposed direct physical interaction between STIM1 and Orai1 to be a mechanism for SOCE activation (10, 12, 18, 34, 35, 41) . This idea was strongly supported by several important findings. First, coimmunoprecipitation of overexpressed STIM1 and Orai1 was shown in S2 cells (41) and human embryonic kidney 293 (HEK293) cells (39) . Second, overexpression of both proteins resulted in remarkable amplification of I CRAC (28, 34, 44) . Third, Förster resonance energy transfer (FRET) between fluorescently tagged STIM1 and Orai1 was reported (23) , indicating their very close spatial proximity. Fourth, overexpression of the COOH terminus part of STIM1 along with full-length Orai1 was reported to be sufficient for SOCE activation (12) . All these data strongly supported the idea of direct conformational coupling of STIM1 to Orai1 as a straightforward mechanism of signal transduction and SOCE activation. However, these studies did not consider the possibility that intermediate steps and additional molecular components may be required for STIM1/ Orai1 colocalization, mutual interaction, and signal transduction from the ER to the PM. In an alternative model (31) , SOCE activation was shown to require a diffusible messenger(s) and specific variant of phospholipase A 2 (PLA 2 ) as additional components for signal transduction from the ER to the PM (for all the details, see reviews in Refs. 3 and 4). The need for an additional intermediate(s) between STIM1 and Orai1 was also strongly supported by recent findings from Dr. Balla's group (38) , which demonstrated that colocalization of STIM1 and Orai1 does not occur in narrow (4 -6 nm) junctions but happens only in the areas where a larger (12-14 nm) gap exists between the ER and the PM. Thus the question remains unanswered as to whether direct physical interaction between STIM1 and Orai1 may be required and sufficient for their accumulation in puncta and SOCE activation or whether additional elements could participate in signal transduction from depleted stores to the PM channel.
This study was designed to test several important predictions of the conformational coupling model and to obtain new data that will either support or challenge the physical coupling of STIM1 and Orai1 as the sole mechanism for puncta formation and SOCE activation. If the mutual presence and direct interaction of STIM1 with Orai1 are indeed required and sufficient, one could expect that there should be a very strict correlation between expression of both these proteins, their accumulation in puncta, and activation of Orai1 and I CRAC . In contrast, the results of our experiments yielded numerous examples of STIM1 accumulation in puncta independently of Orai1 and Orai1 and I CRAC activation independently of STIM1, which challenge the predictions of the conformational coupling model. New evidence suggests that the SOCE mechanism may be a much more complex phenomenon and may require the presence of an additional intermediate element(s) that can mediate puncta formation and signal transduction from STIM1 in the ER to Orai1 in the PM.
MATERIALS AND METHODS
Cells and transfections. HEK293 cells were obtained from American Type Culture Center (ATCC) and grown in DMEM containing 4.5 mg/ml glucose supplemented with 10% heat-inactivated fetal bovine serum (GIBCO), 10 U/ml penicillin, and 10 mg/ml streptomycin at 37°C in the atmosphere of 5% CO 2. Transient transfections of HEK293 cells were performed using jetPEI transfection factor (PolyPlus) according to the protocol suggested by the manufacturer. Standard transfection rate was ϳ70 -90%.
Rat basophilic leukemia (RBL-2H3) cells were obtained from ATCC, cultured, and transfected as described previously (6, 7) . Briefly, cells were maintained in minimum essential medium supplemented with 10% heat-inactivated fetal bovine serum (GIBCO), 1% L-glutamine, 10 U/ml penicillin, and 10 mg/ml streptomycin at 37°C. RBL cells were transiently transfected using Nucleofector (Amaxa Biosystems) according to the protocol provided by the manufacturer. Standard transfection rate was ϳ50 -70%. For visual identification of transfected cells for patch clamp experiments, green fluorescent protein (GFP) constructs (2 g) were added along with all constructs to mark transfected cells.
DNA constructs. Sequences encoding Orai1 (GenBank acc. no. NM032790) and STIM1 (GenBank acc. no. NM003156) were amplified by PCR and cloned in frame into the pEGFP-N1 and/or pmCherry-N1 vectors (Clontech) with the use of BglII and EcoRI restriction sites. Recombinant DNA plasmids were purified with a QIAGEN Plasmid Maxi Kit (Qiagen).
Molecular downregulation of STIM1 and Orai1. RBL-2H3 cells were transfected with either scrambled RNA (Ambion), or siRNA against rat STIM1 (5Ј-AAGGCTCTGGATACAGTGCTC-3Ј) or siRNA against rat Orai1 (5Ј-GUCCACAACCUCAACUCCTT-3Ј) as previously described(7).
HEK293 cells were cotransfected with plasmid DNA encoding STIM GFP (or STIM1 Cherry ), along with either scrambled RNA (Ambion) or siRNA against human Orai1 (5Ј-CCCUUCGGCCUGAUCU-UUAUCGUCU-3Ј) (Invitrogen). Lipofectamine 2000 (Invitrogen) was used for transfection of HEK293 cells, and Nucleofector (Amaxa Biosystems) was used for RBL cells. Cells were investigated 48 -72 h after transfection.
Imaging experiments. A Nikon TE2000 wide-field system with a 60ϫ oil immersion objective (1.4 NA) was used to image individual cells. Before imaging experiments, cells were passed onto glass-bottom dishes (MatTek) and studied 24 -36 h after transfection. During imaging experiments, cells were maintained in extracellular buffer (125 mM NaCl, 5 mM KCl, 1.5 mM MgCl2, 20 mM HEPES, 10 mM glucose, and 1.5 mM CaCl2, pH 7.4) at room temperature. Fluorescence was monitored using the following filter sets (Chroma): 1) ET470/40 (excitation), ET525/50 (emission), and T495LP (dichroic) for GFP and 2) ET560/40 (excitation), ET630/75 (emission), and T585LP (dichroic) for mCherry.
Stack of images was taken at Z intervals of 0.3 m and then deconvolved with the AutoQuant Module in the NIS-elements software (Nikon).
Ca 2Ϯ influx studies. Cells were loaded with Fura-2 AM, and changes in intracellular Ca 2ϩ (measured as F340/F380 ratio) were monitored as previously described (6, 7). Briefly, a dual-excitation fluorescence imaging system (Intracellular Imaging) was used for studies of individual cells. The changes in intracellular Ca 2ϩ were expressed as ⌬Ratio, which was calculated as the difference between the peak F340/F380 ratio after and before extracellular Ca 2ϩ was added. Data were summarized from Electrophysiology. Whole-cell currents were recorded in RBL cells using standard whole-cell (dialysis) patch-clamp technique as previously described (6) . An Axopatch 200B amplifier was used, and data were filtered at 1 kHz and digitized at 5 kHz. Pipettes were used with tip resistance of 2-4 M⍀. After breaking into the cell, the holding potential was 0 mV, and ramp depolarizations (from Ϫ100 to ϩ100 mV, 200 ms) were applied every 3 s. The amplitude of the current was expressed in pA/pF. The time course of current development was analyzed at Ϫ80 mV for each individual cell, and summary data for 5-10 cells are shown in the figures. Average current/voltage (I/V) relationships are shown during ramp depolarization after the current reached its maximum. Passive leakage current with zero reversal potential (at the moment of breaking into the cell or after CRAC inhibition with 10 M diethylstilbestrol; Ref. 42) was subtracted. Intracellular (pipette) solution contained (in mM): 145 CsGlutamate, 3 MgCl 2, 10 HEPES, (pH 7.2), and 0.1 BAPTA, which by itself does not cause store depletion (6) . In experiments with Orai1 overexpression, 20 mM BAPTA was used in the pipette. In experiments in which calcium influx factor (CIF) presence was indicated, HPLC-purified CIF extract from activated platelets (prepared as specified in previously, Ref. Puncta analysis. Number, size, and area of puncta of fluorescently tagged STIM1 within HEK293 cells treated with thapsigargin (TG) were analyzed using ImageJ software (National Institutes of Health). Images were processed with the use of a convolve filter followed by the particle analysis function. The same setting [size: 3-14 (pixel 2 ), circularity: 0 -0.3] was used for all images. Summary data were normalized to cell surface and presented as average Ϯ SE from five representative cells in each group.
Statistical analysis. Summary data are presented as means Ϯ SE. Student's t-test was used to determine the statistical significance of the obtained data. Data were considered significant at P Ͻ 0.01 (see significance levels in the individual figure legends).
RESULTS
In this study, HEK293 and RBL-2H3 cell lines were used as complementary models suitable for a wide range of experimental approaches that allowed us to either overexpress fluorescently labeled Orai1 and/or STIM1 or to knock down endogenous molecules to study correlation between STIM1 and Orai1 expression, puncta formation, and activation of I CRAC and SOCE. Cherry and Orai1 GFP accumulation and colocalization in puncta were observed when the cells were treated with TPEN (Fig. 1B) , which has been shown to mimic TG effects and trigger SOCE in different cell types (6, 11) .
Thus not only store depletion (with TG) but also simple reduction in ER intraluminal free Ca 2ϩ concentration (by TPEN) without Ca 2ϩ changes in cytosol can trigger STIM1 and Orai1 accumulation in the same puncta.
Orai1 is not required for STIM1 accumulation in puncta. To test how strict the correlation is between expression of STIM1 and Orai1, puncta formation, and SOCE activation, we examined the process of Orai1 and STIM1 accumulation in puncta. For this purpose, TG-induced translocation of fluorescently tagged STIM1 (STIM1 Cherry or STIM1 GFP ) into puncta and activation of SOCE were investigated in HEK293 cells, in which Orai1 was up-or downregulated. First, we confirmed that, even when STIM1 was expressed alone in HEK293 ( Fig. 2A) , TG caused its accumulation in puncta, which was consistent with findings by others (27, 33) . In these STIM1-overexpressing HEK cells, TG also triggered SOCE activation, which suggested a significant amount of endogenous Orai1 being present and involved in HEK cell responses. Overexpression of exogenous Orai1 GFP along with STIM1 Cherry (like in Fig. 1A ) resulted in about 50% increase of SOCE (Fig. 2B) , consistent with creation of a monster I CRAC when these two molecules are coexpressed (28, 34, 44) ; Ca 2ϩ influx increased from ⌬R ϭ 3.24 Ϯ 0.14, n ϭ 53 in STIM1-expressing cells to ⌬R ϭ 6.37 Ϯ 0.84, n ϭ 41 in cells expressing both, Orai1 and STIM1 (Fig. 3A) . However, overexpression of Orai1 and dramatic increase in SOCE was not accompanied by any visible changes in the pattern, number, or size of STIM1 GFP puncta ( Fig. 2B and Fig. 3, B and C) . Surprisingly, when, instead of overexpression, Orai1 was knocked down (by siRNA) and SOCE could not be detected (Fig. 2C and Fig. 3A) , we found that STIM1 GFP still formed puncta (Fig. 2C ) that was identical to that in cells overexpressing Orai1 (Fig. 2B) . Thus STIM1 was able to accumulate and form identical puncta independently on the presence or absence of Orai1 and SOCE activation (Fig. 3) . The fact that normal STIM1 puncta are formed in the cells in which endogenous Orai1 was knocked down strongly suggests that Orai1 is not needed for STIM1 accumulation in puncta.
STIM1 accumulation in puncta is not sufficient for Orai1 accumulation. When HEK cells were cotransfected with STIM1
Cherry and Orai1 GFP (using 0.4 g of cDNA for STIM1 and 0.2 g for Orai1, respectively), the majority of the cells did not show any significant accumulations of STIM1 or Orai1 under resting conditions and formed puncta only upon their stimulation with TG or TPEN, as shown in Fig. 1 . However, in a significant number (20 -40%) of resting (unstimulated) HEK293 cells, STIM1
Cherry could be found in puncta-like patches (Fig. 4A) , whereas Orai1
GFP remained evenly distributed throughout the PM (Fig. 4C ) and did not show any significant preference for the structures already preformed by STIM1
Cherry . In these cells, TG application did not produce any additional change in the distribution pattern of STIM1 Cherry (Fig. 4B ), but it caused Orai1 GFP to translocate and accumulate exactly in STIM1
Cherry patches (Fig. 4D ). Thus accumulation of STIM1 was clearly not sufficient for Orai1 accumulation in the same areas. The possibility of temporal and functional separation of STIM1 and Orai1 accumulation in puncta suggests that they can be driven by two independent processes.
I CRAC can be activated in STIM1-deficient cells. To further test the role of STIM1 in activation of Orai1 channels, we studied SOCE and I CRAC (a whole-cell current through Orai1 channels) in control RBL cells and RBL cells in which STIM1 or Orai1 were knocked down. In full agreement with the reports on the important role of STIM1 and Orai1 in Ca 2ϩ entry activated by depletion of the stores, molecular downregulation of STIM1 or Orai1 (using transient cell transfection with corresponding siRNAs) resulted in dramatic inhibition of Ca 2ϩ influx triggered by TG in RBL cells (Fig. 5) . To test whether STIM1 is indeed essential for activation of Orai1-encoded CRAC channels in RBL cells, we tested the impact of STIM1 downregulation on the activation of I CRAC via multiple stimuli. In our earlier studies (6), we demonstrated that I CRAC in RBL cells can be activated equally well by store depletion (with TG or BAPTA) or by cell dialysis with CIF, a diffusible messenger produced by depleted stores (4) .
When RBL cells were treated with TG to initiate the signal by depletion of the stores, I CRAC developed in control but not in cells transfected with STIM1 siRNA (Fig. 6A) , which was totally consistent with the absence of TG-induced Ca 2ϩ entry in STIM1-deficient cells. Surprisingly, we found that a totally normal I CRAC developed in the same STIM1-deficient cells when depletion of the stores was bypassed. Figure 6B shows that RBL cell dialyzed with CIF (extracted from platelets with depleted stores, as described in our earlier publications, Ref. 6) activated I CRAC not only in control but also in STIM1-deficient RBL cells, in which TG-induced I CRAC and SOCE were inhibited. It is important to mention that, in contrast to STIM1, knockdown of either Orai1 (with siRNA) or calcium-independent PLA 2 -␤ (iPLA 2 ␤) (with antisense) significantly inhibited CIF-induced I CRAC (Fig. 7A) , confirming that CIF activates the same iPLA 2 ␤-dependent Orai1-encoded CRAC channels that can also be activated by simple store depletion (with BAPTA or TG). Moreover, when Orai1 but not STIM1 was overexpressed, RBL cell dialysis with CIF resulted in activation of a "monster" I CRAC (Fig. 7B) . Thus I CRAC appeared to be present and fully functional in STIM1-deficient cells and could be easily activated when the store-dependent step in the SOCE pathway was bypassed by cell dialysis with CIF.
DISCUSSION
This study tested some predictions of the conformational coupling model, and the results revealed a much more complex behavior of STIM1 and Orai1 than what one could expect on the basis of their direct physical interaction as the sole requirement for puncta formation and I CRAC activation. Although we observed STIM1 and Orai1 accumulation and colocalization in punctate areas, we found examples of the lack of correlation between expression of STIM1 and Orai1 and their accumulation in puncta. First, Orai1 appeared to be not needed for STIM1 accumulation in puncta; STIM1 was able to form identical punctuate structures in HEK293 cells in which Orai1 was either knocked down or overexpressed. Importantly, STIM1 accumulation in puncta showed no correlation with SOCE activation. Furthermore, accumulation of STIM1 in puncta was not necessarily followed by Orai1 accumulation. Our results demonstrated that, in the absence of cell stimulation, these two events could be separated in time (when STIM1 is already in puncta while Orai1 is not), and cell stimulation (leading to store depletion) may be required for their final colocalization. It suggests that accumulation of STIM1 is not sufficient for Orai1 accumulation into the same punctuate structures, which in turn indicates that, at least in some cells, STIM1 does not directly drive Orai1 translocation. These examples demonstrate that STIM1 and Orai1 accumulation in the same areas can show a much higher degree of independence than could be expected if their colocalization and signal transduction was dictated by their direct physical coupling.
Since molecular knockdown of either Orai1 or STIM1 could totally impair SOCE activation, it does not seem likely that other variants of these molecules play a vital role in this process, but they can certainly be involved in regulation and fine tuning of SOCE mechanism, as proposed by several recent studies (5, 8, 17, 24, 26) .
Existence of an additional structural and functional linker(s) between STIM1 and Orai1 can explain accumulating data that do not fit into their direct coupling models and may provide an alternative mechanism that can explain their functional independence. It can easily explain not only the findings reported here but also the findings of Dr. Balla's group (38) , who recently demonstrated that STIM1 and Orai1 colocalization occur in the areas in which the ER and PM are separated by a gap that can be too big for their direct interaction. It is important to emphasize that the apparent requirement for the molecular linker between STIM1 and Orai1 does not contradict any of the studies that demonstrated their close spatial and functional proximity, including reported FRET between STIM1 and Orai1 (15, 23) . Indeed, colocalization of fluorescently tagged proteins within ϳ10 nM of space between the ER and PM membranes may allow energy transfer even without their physical interaction. An indirect evidence for such possibility comes from the studies by Muik et al. (15, 23) , who presented a strong proof that only COOH (but not NH 2 ) terminus of Orai1 is important for its colocalization with STIM1, but at the same time similar FRET could be detected between fluorescently tagged STIM1 and Orai1 when it was tagged at either COOH or NH 2 terminus. Thus FRET can be observed between STIM1 and the different parts of Orai1, even if they are not involved in their interaction but may simply come in close proximity to STIM1.
The most striking evidence for a functional gap that may exist between STIM1 and Orai1 came from the experiments that demonstrated activation of normal I CRAC in STIM1-deficient cells. Indeed, if physical interaction of STIM1 with Orai1 is the mechanism of SOCE, activation of I CRAC by any means should be impossible in STIM1-deficient cells. In contrast, the result showed that CRAC channels could be equally well activated in cells with or without STIM1 when ER-delimited STIM1-dependent steps following depletion of the stores were bypassed by cell dialysis with CIF (production of which we have recently shown to be an early STIM1-dependent event in the ER, Ref. 7). The fact that CIF dialysis can cause activation of a monster I CRAC in cells that overexpress only Orai1 (without STIM1) is also inconsistent with direct conformational coupling models and suggests a different explanation for monster I CRAC phenomenon. It further supports the role of STIM1 as a trigger for production of CIF (7), which can activate Orai1 via iPLA 2 ␤-dependent mechanism. All these results are totally consistent with our earlier findings (6) showing that, even in the absence of store depletion, activation of normal I CRAC can be achieved by direct activation of iPLA 2 ␤ with either CIF or CaM inhibitory peptide, which are both able to displace inhibitory CaM from iPLA 2 ␤ (for the details on the CIF-iPLA 2 ␤-dependent model of SOCE activation, please see Ref. 4) . So far none of the conformational coupling models could account for the crucial role of iPLA 2 ␤ in SOCE activation, which was confirmed by different investigators in numerous cell types (2, 6, 21, 29 -32, 37, 43) as well as by genetic screening of Drosophila melanogaster published by Vig et al. (39) . Thus iPLA 2 ␤ may be one of the molecular and/or functional linkers between STIM1 and Orai1, which need to be further investigated.
Although direct coupling of ER-resident STIM1 to PMresident Orai1 may be rightfully considered as the most straightforward mechanism for signal transduction, new evidence suggests that the SOCE mechanism may be a much more complex phenomenon. It may require the presence and functional activity of additional intermediate element(s) that can mediate STIM1 and Orai1 accumulation in puncta and can orchestrate signal transduction from the ER to the PM leading to the eventual activation of SOCE.
